{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:24:15Z","timestamp":1793499855248,"version":"4.5.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":8,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Ferroptosis is a newly identified programmed cell death induced by iron-driven lipid peroxidation and implicated as a potential approach for tumor treatment. Breast tumors develop in a complex microenvironment whose main component is adipose tissue and gain aggressiveness through increased fatty acid uptake. Here, we demonstrated that palmitic acid (PA) induced ferroptosis in triple negative breast cancers (TNBC). We found that PA increases the protein expression levels of the long-chain fatty acid transporter CD36, leading to increased lipid uptake. Mechanistically, overexpression of CD36 increases lipid peroxidation, mitochondrial ROS production, the labile iron pool, and especially Fe\n                    <jats:sup>2+<\/jats:sup>\n                    content. Additionally, we found increased expression of ferroptotic target genes (HMOX1, ACSL1, SAT1) and decreased of anti-ferroptotic genes (GPX4 and FSP1) in TNBC following PA exposure. Overexpression of CD36 did not induce ferroptosis in estrogen receptor positive breast cancer. Clinically, higher CD36 expression correlated with the luminal androgen receptor (LAR) subtype of TNBC, known to exhibit a higher sensitivity to ferroptosis. Altogether, these data provide evidence for an essential role of the CD36 protein in the ferroptotic process induced by the saturated fatty acid PA, opening potential new therapeutic approaches promoting ferroptosis in the most aggressive breast cancers.\n                  <\/jats:p>","DOI":"10.1038\/s41419-026-08460-3","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T10:46:06Z","timestamp":1770806766000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["CD36 enhances sensitivity of triple negative breast cancer cells to palmitate-induced ferroptosis"],"prefix":"10.1038","volume":"17","author":[{"given":"Lara","family":"Closset","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Foy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lila","family":"Louadj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Pramil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Marangoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Bieche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5368-9022","authenticated-orcid":false,"given":"Mich\u00e8le","family":"Sabbah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,11]]},"reference":[{"key":"8460_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"8460_CR2","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou CM, S\u00f8rlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature. 2000;406:747\u201352.","journal-title":"Nature"},{"key":"8460_CR3","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"8460_CR4","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.3892\/or.2017.5864","volume":"38","author":"J Zhao","year":"2017","unstructured":"Zhao J, Zhi Z, Wang C, Xing H, Song G, Yu X, et al. Exogenous lipids promote the growth of breast cancer cells via CD36. Oncol Rep. 2017;38:2105\u201315.","journal-title":"Oncol Rep"},{"key":"8460_CR5","doi-asserted-by":"publisher","first-page":"4893","DOI":"10.7150\/thno.36037","volume":"9","author":"J Wang","year":"2019","unstructured":"Wang J, Li Y. CD36 tango in cancer: signaling pathways and functions. Theranostics. 2019;9:4893\u2013908.","journal-title":"Theranostics"},{"key":"8460_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.imlet.2023.12.002","volume":"265","author":"M Jiang","year":"2024","unstructured":"Jiang M, Karsenberg R, Bianchi F, van den Bogaart G. CD36 as a double-edged sword in cancer. Immunol Lett. 2024;265:7\u201315.","journal-title":"Immunol Lett"},{"key":"8460_CR7","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20211314","volume":"219","author":"Y Chen","year":"2022","unstructured":"Chen Y, Zhang J, Cui W, Silverstein RL. CD36, a signaling receptor and fatty acid transporter that regulates immune cell metabolism and fate. J Exp Med. 2022;219:e20211314.","journal-title":"J Exp Med"},{"key":"8460_CR8","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.1016\/j.celrep.2019.11.008","volume":"29","author":"WW Feng","year":"2019","unstructured":"Feng WW, Wilkins O, Bang S, Ung M, Li J, An J, et al. CD36-mediated metabolic rewiring of breast cancer cells promotes resistance to HER2-targeted therapies. Cell Rep. 2019;29:3405\u201320.e5.","journal-title":"Cell Rep"},{"key":"8460_CR9","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1038\/s41388-017-0093-z","volume":"37","author":"A Ladanyi","year":"2018","unstructured":"Ladanyi A, Mukherjee A, Kenny HA, Johnson A, Mitra AK, Sundaresan S, et al. Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis. Oncogene. 2018;37:2285\u2013301.","journal-title":"Oncogene"},{"key":"8460_CR10","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau5758","volume":"11","author":"MJ Watt","year":"2019","unstructured":"Watt MJ, Clark AK, Selth LA, Haynes VR, Lister N, Rebello R, et al. Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer. Sci Translat Med. 2019;11:eaau5758.","journal-title":"Sci Translat Med"},{"key":"8460_CR11","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nature20791","volume":"541","author":"G Pascual","year":"2017","unstructured":"Pascual G, Avgustinova A, Mejetta S, Mart\u00edn M, Castellanos A, Attolini CSO, et al. Targeting metastasis-initiating cells through the fatty acid receptor CD36. Nature. 2017;541:41\u20135.","journal-title":"Nature"},{"key":"8460_CR12","doi-asserted-by":"publisher","first-page":"E2012","DOI":"10.3390\/cancers11122012","volume":"11","author":"M Zaoui","year":"2019","unstructured":"Zaoui M, Morel M, Ferrand N, Fellahi S, Bastard JP, Lamazi\u00e8re A, et al. Breast-associated adipocytes secretome induce fatty acid uptake and invasiveness in breast cancer cells via CD36 independently of body mass index, menopausal status and mammary density. Cancers. 2019;11:E2012.","journal-title":"Cancers"},{"key":"8460_CR13","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1007\/s12094-022-03035-y","volume":"25","author":"M Zaoui","year":"2023","unstructured":"Zaoui M, Morel M, Louadj L, Ferrand N, Lamazi\u00e8re A, Uzan C, et al. Adipocytes secretome from normal and tumor breast favor breast cancer invasion by metabolic reprogramming. Clin Transl Oncol. 2023;25:1389\u2013401.","journal-title":"Clin Transl Oncol"},{"key":"8460_CR14","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of non-apoptotic cell death. Cell. 2012;149:1060\u201372.","journal-title":"Cell"},{"key":"8460_CR15","first-page":"1","volume":"11","author":"J Li","year":"2020","unstructured":"Li J, Cao F, Yin Hliang, Huang Zjian, Lin Ztao, Mao N, et al. Ferroptosis: past, present and future. Cell Death Dis. 2020;11:1\u201313.","journal-title":"Cell Death Dis"},{"key":"8460_CR16","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/s41580-025-00843-2","volume":"26","author":"E Mishima","year":"2025","unstructured":"Mishima E, Nakamura T, Doll S, Proneth B, Fedorova M, Pratt DA, et al. Recommendations for robust and reproducible research on ferroptosis. Nat Rev Mol Cell Biol. 2025;26:615\u201330.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8460_CR17","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41388-022-02537-x","volume":"42","author":"D Li","year":"2023","unstructured":"Li D, Wang Y, Dong C, Chen T, Dong A, Ren J, et al. CST1 inhibits ferroptosis and promotes gastric cancer metastasis by regulating GPX4 protein stability via OTUB1. Oncogene. 2023;42:83\u201398.","journal-title":"Oncogene"},{"key":"8460_CR18","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","volume":"22","author":"G Lei","year":"2022","unstructured":"Lei G, Zhuang L, Gan B. Targeting ferroptosis as a vulnerability in cancer. Nat Rev Cancer. 2022;22:381\u201396.","journal-title":"Nat Rev Cancer"},{"key":"8460_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-019-1177-1","volume":"21","author":"A Nagpal","year":"2019","unstructured":"Nagpal A, Redvers RP, Ling X, Ayton S, Fuentes M, Tavancheh E, et al. Neoadjuvant neratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2+ve breast cancer metastasis. Breast Cancer Res. 2019;21:94.","journal-title":"Breast Cancer Res"},{"key":"8460_CR20","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1002\/ijc.28159","volume":"133","author":"C Louandre","year":"2013","unstructured":"Louandre C, Ezzoukhry Z, Godin C, Barbare JC, Mazi\u00e8re JC, Chauffert B, et al. Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenib. Int J Cancer. 2013;133:1732\u201342.","journal-title":"Int J Cancer"},{"key":"8460_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-020-00230-3","volume":"8","author":"Z Li","year":"2020","unstructured":"Li Z, Chen L, Chen C, Zhou Y, Hu D, Yang J, et al. Targeting ferroptosis in breast cancer. Biomark Res. 2020;8:58.","journal-title":"Biomark Res"},{"key":"8460_CR22","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cmet.2022.09.021","volume":"35","author":"F Yang","year":"2023","unstructured":"Yang F, Xiao Y, Ding JH, Jin X, Ma D, Li DQ, et al. Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy. Cell Metabolism. 2023;35:84\u2013100.e8.","journal-title":"Cell Metabolism"},{"key":"8460_CR23","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41586-025-08974-4","volume":"642","author":"T Ca\u00f1eque","year":"2025","unstructured":"Ca\u00f1eque T, Baron L, M\u00fcller S, Carmona A, Colombeau L, Versini A, et al. Activation of lysosomal iron triggers ferroptosis in cancer. Nature. 2025;642:492\u2013500.","journal-title":"Nature"},{"key":"8460_CR24","doi-asserted-by":"crossref","unstructured":"Wahida A, Conrad M. Decoding ferroptosis for cancer therapy. Nat Rev Cancer. 2025;25:1\u201315.","DOI":"10.1038\/s41568-025-00864-1"},{"key":"8460_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2024.103236","volume":"5","author":"GE Miner","year":"2024","unstructured":"Miner GE, Cohen S. Protocol for monitoring fatty acid trafficking from lipid droplets to mitochondria in cultured cells. STAR Protocols. 2024;5:103236.","journal-title":"STAR Protocols"},{"key":"8460_CR26","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.chembiol.2008.02.010","volume":"15","author":"WS Yang","year":"2008","unstructured":"Yang WS, Stockwell BR. Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. Chem Biol. 2008;15:234\u201345.","journal-title":"Chem Biol"},{"key":"8460_CR27","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1172\/JCI45014","volume":"121","author":"BD Lehmann","year":"2011","unstructured":"Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, Shyr Y, et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Investig. 2011;121:2750\u201367.","journal-title":"J Clin Investig"},{"key":"8460_CR28","doi-asserted-by":"publisher","first-page":"4768","DOI":"10.1158\/1078-0432.CCR-23-1242","volume":"30","author":"B Jovanovi\u0107","year":"2024","unstructured":"Jovanovi\u0107 B, Church SE, Gorman KM, North K, Richardson ET, DiLullo M, et al. Integrative multiomic profiling of triple-negative breast cancer for identifying suitable therapies. Clin Cancer Res. 2024;30:4768\u201379.","journal-title":"Clin Cancer Res"},{"key":"8460_CR29","doi-asserted-by":"crossref","unstructured":"Burstein MD, Tsimelzon A, Poage GM, Covington KR, Contreras A, Fuqua SAW, et al. Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer. Clin Cancer Res. 2015;21:1688\u201398.","DOI":"10.1158\/1078-0432.CCR-14-0432"},{"key":"8460_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41523-021-00324-7","volume":"7","author":"J Gyamfi","year":"2021","unstructured":"Gyamfi J, Yeo JH, Kwon D, Min BS, Cha YJ, Koo JS, et al. Interaction between CD36 and FABP4 modulates adipocyte-induced fatty acid import and metabolism in breast cancer. npj Breast Cancer. 2021;7:1\u201318.","journal-title":"npj Breast Cancer"},{"key":"8460_CR31","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.cmet.2021.02.015","volume":"33","author":"X Ma","year":"2021","unstructured":"Ma X, Xiao L, Liu L, Ye L, Su P, Bi E, et al. CD36-mediated ferroptosis dampens intratumoral CD8+ T cell effector function and impairs their antitumor ability. Cell Metab. 2021;33:1001\u201312.e5.","journal-title":"Cell Metab"},{"key":"8460_CR32","doi-asserted-by":"publisher","first-page":"3664","DOI":"10.1111\/febs.16772","volume":"290","author":"H Kuang","year":"2023","unstructured":"Kuang H, Sun X, Liu Y, Tang M, Wei Y, Shi Y, et al. Palmitic acid-induced ferroptosis via CD36 activates ER stress to break calcium-iron balance in colon cancer cells. FEBS J. 2023;290:3664\u201387.","journal-title":"FEBS J"},{"key":"8460_CR33","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.chembiol.2018.11.016","volume":"26","author":"L Magtanong","year":"2019","unstructured":"Magtanong L, Ko PJ, To M, Cao JY, Forcina GC, Tarangelo A, et al. Exogenous monounsaturated fatty acids promote a ferroptosis-resistant cell state. Cell Chem Biol. 2019;26:420\u201332.e9.","journal-title":"Cell Chem Biol"},{"key":"8460_CR34","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41586-020-2623-z","volume":"585","author":"JM Ubellacker","year":"2020","unstructured":"Ubellacker JM, Tasdogan A, Ramesh V, Shen B, Mitchell EC, Martin-Sandoval MS, et al. Lymph protects metastasizing melanoma cells from ferroptosis. Nature. 2020;585:113\u20138.","journal-title":"Nature"},{"key":"8460_CR35","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/j.cmet.2021.05.016","volume":"33","author":"E Dierge","year":"2021","unstructured":"Dierge E, Debock E, Guilbaud C, Corbet C, Mignolet E, Mignard L, et al. Peroxidation of n-3 and n-6 polyunsaturated fatty acids in the acidic tumor environment leads to ferroptosis-mediated anticancer effects. Cell Metab. 2021;33:1701\u201315.e5.","journal-title":"Cell Metab"},{"key":"8460_CR36","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1038\/s44321-024-00090-6","volume":"16","author":"N Lorito","year":"2024","unstructured":"Lorito N, Subbiani A, Smiriglia A, Bacci M, Bonechi F, Tronci L, et al. FADS1\/2 control lipid metabolism and ferroptosis susceptibility in triple-negative breast cancer. EMBO Mol Med. 2024;16:1533\u201359.","journal-title":"EMBO Mol Med"},{"key":"8460_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2024.114134","volume":"440","author":"M Guo","year":"2024","unstructured":"Guo M, Huang X, Zhang J, Huang Y, Tang Y, Wen H, et al. Palmitic acid induces \u03b2-cell ferroptosis by activating ceramide signaling pathway. Exp Cell Res. 2024;440:114134.","journal-title":"Exp Cell Res"},{"key":"8460_CR38","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.yjmcc.2020.10.010","volume":"150","author":"N Wang","year":"2021","unstructured":"Wang N, Ma H, Li J, Meng C, Zou J, Wang H, et al. HSF1 functions as a key defender against palmitic acid-induced ferroptosis in cardiomyocytes. J Mol Cell Cardiol. 2021;150:65\u201376.","journal-title":"J Mol Cell Cardiol"},{"key":"8460_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07354-0","volume":"16","author":"J Cao","year":"2025","unstructured":"Cao J, Zhou T, Wu T, Lin R, Huang J, Shi D, et al. Targeting estrogen-regulated system xc\u2212 promotes ferroptosis and endocrine sensitivity of ER+ breast cancer. Cell Death Dis. 2025;16:30.","journal-title":"Cell Death Dis"},{"key":"8460_CR40","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1038\/s41586-025-09389-x","volume":"645","author":"W Tonnus","year":"2025","unstructured":"Tonnus W, Maremonti F, Gavali S, Schlecht MN, Gembardt F, Belavgeni A, et al. Multiple oestradiol functions inhibit ferroptosis and acute kidney injury. Nature. 2025;645:1011\u20139.","journal-title":"Nature"},{"key":"8460_CR41","doi-asserted-by":"publisher","first-page":"115164","DOI":"10.18632\/oncotarget.23046","volume":"8","author":"SH Hong","year":"2017","unstructured":"Hong SH, Lee DH, Lee YS, Jo MJ, Jeong YA, Kwon WT, et al. Molecular crosstalk between ferroptosis and apoptosis: emerging role of ER stress-induced p53-independent PUMA expression. Oncotarget. 2017;8:115164\u201378.","journal-title":"Oncotarget"},{"key":"8460_CR42","doi-asserted-by":"crossref","unstructured":"Qiu Y, H\u00fcther JA, Wank B, Rath A, Tykwe R, Aldrovandi M, et al. Interplay of ferroptotic and apoptotic cell death and its modulation by BH3-mimetics. Cell Death Differ. 2025;32:1\u201316.","DOI":"10.1101\/2024.09.04.611207"},{"key":"8460_CR43","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/s41557-020-0513-5","volume":"12","author":"S M\u00fcller","year":"2020","unstructured":"M\u00fcller S, Sindikubwabo F, Ca\u00f1eque T, Lafon A, Versini A, Lombard B, et al. CD44 regulates epigenetic plasticity by mediating iron endocytosis. Nat Chem. 2020;12:929\u201338.","journal-title":"Nat Chem"},{"key":"8460_CR44","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.gendis.2022.12.003","volume":"11","author":"Y Ma","year":"2024","unstructured":"Ma Y, Huang L, Zhang Z, Yang P, Chen Q, Zeng X, et al. CD36 promotes tubular ferroptosis by regulating the ubiquitination of FSP1 in acute kidney injury. Genes Diseases. 2024;11:449\u201363.","journal-title":"Genes Diseases"},{"key":"8460_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2025.103528","volume":"80","author":"N Jin","year":"2025","unstructured":"Jin N, Qian YY, Jiao XF, Wang Z, Li X, Pan W, et al. Niraparib restricts intraperitoneal metastases of ovarian cancer by eliciting CD36-dependent ferroptosis. Redox Biol. 2025;80:103528.","journal-title":"Redox Biol"},{"key":"8460_CR46","doi-asserted-by":"crossref","unstructured":"Hassannia B, Wiernicki B, Ingold I, Qu F, Van Herck S, Tyurina YY, et al. Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma. J Clin Investig. 2018;128:3341\u201355.","DOI":"10.1172\/JCI99032"},{"key":"8460_CR47","doi-asserted-by":"publisher","first-page":"E6806","DOI":"10.1073\/pnas.1607152113","volume":"113","author":"Y Ou","year":"2016","unstructured":"Ou Y, Wang SJ, Li D, Chu B, Gu W. Activation of SAT1 engages polyamine metabolism with p53-mediated ferroptotic responses. Proc Natl Acad Sci USA. 2016;113:E6806\u201312.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8460_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22471-y","volume":"12","author":"A Beatty","year":"2021","unstructured":"Beatty A, Singh T, Tyurina YY, Tyurin VA, Samovich S, Nicolas E, et al. Ferroptotic cell death triggered by conjugated linolenic acids is mediated by ACSL1. Nat Commun. 2021;12:2244.","journal-title":"Nat Commun"},{"key":"8460_CR49","doi-asserted-by":"publisher","first-page":"e87878","DOI":"10.1371\/journal.pone.0087878","volume":"9","author":"N Ferrand","year":"2014","unstructured":"Ferrand N, Gnanapragasam A, Dorothee G, Redeuilh G, Larsen AK, Sabbah M. Loss of WISP2\/CCN5 in estrogen-dependent MCF7 human breast cancer cells promotes a stem-like cell phenotype. PLoS ONE. 2014;9:e87878.","journal-title":"PLoS ONE"},{"key":"8460_CR50","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1002\/ijc.32266","volume":"145","author":"F Coussy","year":"2019","unstructured":"Coussy F, de Koning L, Lavigne M, Bernard V, Ouine B, Boulai A, et al. A large collection of integrated genomically characterized patient-derived xenografts highlighting the heterogeneity of triple-negative breast cancer. Int J Cancer. 2019;145:1902\u201312.","journal-title":"Int J Cancer"},{"key":"8460_CR51","doi-asserted-by":"publisher","first-page":"3989","DOI":"10.1158\/1078-0432.CCR-07-0078","volume":"13","author":"E Marangoni","year":"2007","unstructured":"Marangoni E, Vincent-Salomon A, Auger N, Degeorges A, Assayag F, de Cremoux P, et al. A new model of patient tumor-derived breast cancer xenografts for preclinical assays. Clin Cancer Res. 2007;13:3989\u201398.","journal-title":"Clin Cancer Res"},{"key":"8460_CR52","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1158\/1078-0432.CCR-17-3490","volume":"24","author":"E Marangoni","year":"2018","unstructured":"Marangoni E, Laurent C, Coussy F, El-Botty R, Ch\u00e2teau-Joubert S, Servely JL, et al. Capecitabine efficacy is correlated with TYMP and RB1 expression in PDX established from triple-negative breast cancers. Clin Cancer Res. 2018;24:2605\u201315.","journal-title":"Clin Cancer Res"},{"key":"8460_CR53","doi-asserted-by":"publisher","first-page":"147","DOI":"10.4137\/CIN.S9983","volume":"11","author":"X Chen","year":"2012","unstructured":"Chen X, Li J, Gray WH, Lehmann BD, Bauer JA, Shyr Y, et al. TNBCtype: a subtyping tool for triple-negative breast cancer. Cancer Inform. 2012;11:147\u201356.","journal-title":"Cancer Inform"},{"key":"8460_CR54","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1038\/sj.bjc.6605642","volume":"102","author":"P Workman","year":"2010","unstructured":"Workman P, Aboagye EO, Balkwill F, Balmain A, Bruder G, Chaplin DJ, et al. Guidelines for the welfare and use of animals in cancer research. Br J Cancer. 2010;102:1555\u201377.","journal-title":"Br J Cancer"},{"key":"8460_CR55","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6:pl1.","journal-title":"Sci Signal"},{"key":"8460_CR56","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2:401\u20134.","journal-title":"Cancer Discov"},{"key":"8460_CR57","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1093\/bioinformatics\/btv677","volume":"32","author":"YW Wan","year":"2016","unstructured":"Wan YW, Allen GI, Liu Z. TCGA2STAT: simple TCGA data access for integrated statistical analysis in R. Bioinformatics. 2016;32:952\u20134.","journal-title":"Bioinformatics"},{"key":"8460_CR58","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.ccell.2019.02.001","volume":"35","author":"YZ Jiang","year":"2019","unstructured":"Jiang YZ, Ma D, Suo C, Shi J, Xue M, Hu X, et al. Genomic and transcriptomic landscape of triple-negative breast cancers: subtypes and treatment strategies. Cancer Cell. 2019;35:428\u201340.e5.","journal-title":"Cancer Cell"},{"key":"8460_CR59","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nmeth.3252","volume":"12","author":"W Huber","year":"2015","unstructured":"Huber W, Carey VJ, Gentleman R, Anders S, Carlson M, Carvalho BS, et al. Orchestrating high-throughput genomic analysis with Bioconductor. Nat Methods. 2015;12:115\u201321.","journal-title":"Nat Methods"},{"key":"8460_CR60","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, Birger C, Thorvaldsd\u00f3ttir H, Ghandi M, Mesirov JP, Tamayo P. The molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1:417\u201325.","journal-title":"Cell Syst"},{"key":"8460_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14:7.","journal-title":"BMC Bioinformatics"},{"key":"8460_CR62","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1093\/bib\/bbz158","volume":"22","author":"L Geistlinger","year":"2021","unstructured":"Geistlinger L, Csaba G, Santarelli M, Ramos M, Schiffer L, Turaga N, et al. Toward a gold standard for benchmarking gene set enrichment analysis. Brief Bioinformatics. 2021;22:545\u201356.","journal-title":"Brief Bioinformatics"},{"key":"8460_CR63","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1093\/bib\/bbz074","volume":"21","author":"M Ebrahimpoor","year":"2020","unstructured":"Ebrahimpoor M, Spitali P, Hettne K, Tsonaka R, Goeman J. Simultaneous enrichment analysis of all possible gene-sets: unifying self-contained and competitive methods. Brief Bioinformatics. 2020;21:1302\u201312.","journal-title":"Brief Bioinformatics"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08460-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08460-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08460-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T05:22:21Z","timestamp":1771564941000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08460-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,11]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8460"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08460-3","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,11]]},"assertion":[{"value":"26 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"219"}}